Page last updated: 2024-11-03

procarbazine and Gingival Hyperplasia

procarbazine has been researched along with Gingival Hyperplasia in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Gingival Hyperplasia: Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nicolatou-Galitis, O1
Papadaki, T1
Moschovi, M1
Moshovi, M1
Kamma, JJ1
van Vliet-Constantinidou, C1
Tsoumakas, C1
Kattamis, A1
Tzortzatou-Stathopoulou, F1

Other Studies

1 other study available for procarbazine and Gingival Hyperplasia

ArticleYear
Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.
    Journal of periodontology, 2001, Volume: 72, Issue:1

    Topics: Alveolar Bone Loss; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Dacarb

2001